Latest findings from the IFSO Global Registry Registries offer opportunities to make meaningful comparisons between countries on the demographics, characteristics, operation types and...
Looking forward to IFSO 2024This year’s 27th IFSO World Congress returns to Australia for the first time since the 11th World Congress in Sydney in 2006. We caught...
Obesity, Bariatric and Metabolic Surgery - A Comprehensive Guide (2nd Edition)Following a fantastic response (>250,000 combined chapter downloads) to the publication of ‘Obesity, Bariatric and Metabolic Surgery - A...
Journal Watch 24/04/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Medtronic launches new AI analysis for laparoscopic and robotic-assisted proceduresMedtronic has announced the launch of new AI algorithms for post-operative analysis, providing AI surgical insights across laparoscopic...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditureChinese and Singaporean researchers have discovered that apolipoprotein A-IV (apoA-IV) was significantly increased in diabetic patients...
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesityEli Lilly and Company has announced positive topline results from the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide...
Journal Watch 17/04/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
The status of bariatric surgery in EgyptWith approximately 100 million inhabitants, Egypt is the 14th-most populated country in the world, and the third-most populated in...
The evolution of the UK’s National Bariatric Surgery RegistryIn October 2023, Mr Omar Khan was appointed as the Chair of the British Obesity & Metabolic Surgery Society’s (BOMSS) National Bariatric...
Endoscopic sleeve gastroplasty more cost-effective than with semaglutideAn economic evaluation comparing endoscopic sleeve gastroplasty (ESG) with semaglutide for treating class II obesity has suggested ESG is...
Looking forward to IFSO 2024This year’s 27th IFSO World Congress returns to Australia for the first time since the 11th World Congress in Sydney in 2006. We caught...
No association between suicidal, self-injurious thoughts and actions and GLP-1sThe available evidence does not support a causal association between the Glucagon-Like Peptide-1 receptor agonists (GLP-1) – dulaglutide,...
Latest findings from the IFSO Global Registry Registries offer opportunities to make meaningful comparisons between countries on the demographics, characteristics, operation types and...
FDA approves Wegovy for CVD risk reduction in people with overweight or obesity and established cardiovascular disease